Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Language and Cognition01:27

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted Muscle Reinnervation for Intuitive Prosthetic Control.

Muscle & nerve·2026
Same author

Retrospective Descriptive Case Series on the Use of AMCOP<sup>®</sup> Elastodontic Appliance in Growing Patients with Class III Malocclusion.

Bioengineering (Basel, Switzerland)·2026
Same author

From mixed signals to neural code: compensating volume conduction for noninvasive generic neural interfaces.

Expert review of medical devices·2026
Same author

Author Correction: Implanted microelectrode arrays in reinnervated muscles allow separation of neural drives from transferred polyfunctional nerves.

Nature biomedical engineering·2026
Same author

The role of human papillomavirus in oral squamous cell and verrucous carcinomas: a systematic review with case series.

Oncology reviews·2026
Same author

Changes in transverse dimensions in growing patients treated with AMCOP® and electromyographic assessment with Teethan®.

Frontiers in dental medicine·2026

Related Experiment Video

Updated: Jul 14, 2026

Advancing Dyslexia Assessment in Children Through Computerized Testing
09:00

Advancing Dyslexia Assessment in Children Through Computerized Testing

Published on: August 16, 2024

Ginkgo biloba in dyslexia: a pilot study.

Renato Donfrancesco1, Laura Ferrante

  • 1Department of Child Neuropsychiatry, La Scarpetta Hospital, Piazza Castellani 23, 00151 Rome, Italy.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|May 23, 2007
PubMed
Summary

This study suggests that Ginkgo biloba extract (EGb 761) may help reduce dyslexia symptoms in children. The treatment showed positive results in standardized tests and was well-tolerated.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pediatrics

Background:

  • Dyslexia is a common learning disorder affecting reading and spelling abilities.
  • Standardized plant extracts are increasingly explored for therapeutic potential in various conditions.

Purpose of the Study:

  • To assess the preliminary efficacy and tolerability of EGb 761 (Ginkgo biloba extract) for treating dyslexia in school-aged children.

Main Methods:

  • An open-label trial involving 15 children (ages 5-16) with dyslexia.
  • Administration of a single daily dose of 80 mg EGb 761.
  • Standardized dyslexia tests were conducted at baseline and study completion.

Main Results:

  • All participants completed the trial with EGb 761 showing a significant decrease in dyslexia test scores.

More Related Videos

Assessing Dyslexia at Six Year of Age
15:00

Assessing Dyslexia at Six Year of Age

Published on: May 1, 2020

Related Experiment Videos

Last Updated: Jul 14, 2026

Advancing Dyslexia Assessment in Children Through Computerized Testing
09:00

Advancing Dyslexia Assessment in Children Through Computerized Testing

Published on: August 16, 2024

Assessing Dyslexia at Six Year of Age
15:00

Assessing Dyslexia at Six Year of Age

Published on: May 1, 2020

  • Improvements were noted in word lists, non-word lists, and reading comprehension.
  • Two children reported mild headaches; otherwise, the extract was well-tolerated.

    • Conclusions:

    • EGb 761 demonstrated possible efficacy in reducing dyslexia-related difficulties and acceptable acute tolerability at 80 mg/day.
    • Further investigation through a double-blind trial is warranted to confirm these findings.